Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Controlled Gene Delivery Can Enhance Therapeutic Outcome for Cancer Immune Therapy for Melanoma

26 Dec 2014

Abstract excerpt

Effective delivery still remains a major hurdle in the development of gene based therapies. While technological advances have occurred that have improved delivery in general, there is still a need for controlled delivery in order to achieve therapeutic effects. Gene electrotransfer (GET) can be utilized to accomplish this. Careful selection of parameters used for delivery such as amplitude, duration and number of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Microbial Inactivation Methods
Share to Toxin Mechanisms and Immunotoxins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 25414028
DOI: 10.2174/1566523214666141121111630

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Controlled Gene Delivery Can Enhance Therapeutic Outcome for Cancer Immune Therapy for MelanomaPMID 25414028Read ↗

The effectiveness of calcium electroporation combined with gene electrotransfer of a plasmid encoding IL-12 is tumor type-dependentSemantic proximity Read ↗

Phase I trial of phIL12 plasmid intratumoral gene electrotransfer in patients with basal cell carcinoma in head and neck regionSemantic proximity Read ↗

Gene Therapy of Cancer Based on Interleukin 12Semantic proximity Read ↗

504 Intratumoral delivery of Interleukin-12 DNA via in vivo electroporation leads to regression of injected and non-injected tumors in Merkel cell carcinoma: Final Results of a phase 2 studySemantic proximity Read ↗

Gene Transfer to Subdermal Tissues via a New Gene Gun DesignSemantic proximity Read ↗

Intratumoral expression of IL-12 and CD40 ligand (CD154) from plasmids generates antitumor responses that eliminate tumoral T regsSemantic proximity Read ↗

Non-clinical evaluation of pmIL12 gene therapy for approval of the phase I clinical studySemantic proximity Read ↗

Feasibility study for the use of gene electrotransfer and cell electrofusion as a single-step technique for the generation of activated cancer cell vaccinesSemantic proximity Read ↗

Optimization of the Tet-on System To Regulate Interleukin 12 Expression in the Liver for the Treatment of Hepatic TumorsSemantic proximity Read ↗

Optimizing regulatable gene expression using adenoviral vectorsSemantic proximity Read ↗

Gene expression and immune response kinetics using electroporation-mediated DNA delivery to muscleSemantic proximity Read ↗

Optimization of intradermal vaccination by DNA tattooing in human skinSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.